Indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) combined with conventional therapy for ovarian cancer.

Ovarian cancer is the 7th most common cancer in females [1]. Depending on the stage at diagnosis, treatment typically involves surgery and platinum-based chemotherapy regimens, which have a range of side effects including but not limited to fatigue, nausea and vomiting, pain, insomnia, anemia, and peripheral neuropathy.

A 2018 study published in BMC Cancer looked at the effects of indole-3-carbinol and epigallocatechin-3-gallate (EGCG) in addition to chemotherapy and surgery on overall survival [2].

I3C is a natural compound found primarily in cruciferous vegetables (such as broccoli, kale, and Swiss chard), and EGCG is a natural compound found in green tea. This study demonstrated that I3C and EGCG as 5-year maintenance therapy given before, during and after platinum-based neoadjuvant and adjuvant chemotherapy and surgery significantly prolonged both progression-free and overall survival in patients with stage III and IV ovarian cancer, and also reduced incidence of ascites in recurrent ovarian cancer patients, compared to conventional therapy alone.

[1] https://www.wcrf.org/dietandcancer/ovarian-cancer

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148762/


Written by Dr. Dana Kolenich ND


Disclaimer: The information provided in this blog post is for general informational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.